Jansen J

Stakeholders and Communication Division, European Medicines Agency, 1083 HS Amsterdam, Netherlands.

1 paper

ArticlePsychedelics

Applying the EU Regulatory Framework to Determine the Benefit-Risk Profile of Psychedelics.

Browne K, Bałkowiec-Iskra E, Elferink A +10

Europe PMC2025